EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination

被引:19
作者
Krug, Peter W. [1 ]
Wang, Lingshu [1 ]
Shi, Wei [1 ]
Kong, Wing-Pui [1 ]
Moss, Daniel L. [1 ]
Yang, Eun Sung [1 ]
Fisher, Brian E. [1 ]
Morabito, Kaitlyn M. [1 ]
Mascola, John R. [1 ,2 ]
Kanekiyo, Masaru [1 ]
Graham, Barney S. [1 ,3 ]
Ruckwardt, Tracy J. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] ModeX Therapeut, Natick, MA 01760 USA
[3] Morehouse Sch Med, Dept Med & Microbiol Biochem & Immunol, Atlanta, GA 30310 USA
基金
美国国家卫生研究院;
关键词
ACUTE FLACCID MYELITIS; ENTEROVIRUS D68; MOUTH-DISEASE; 2014; OUTBREAK; KANSAS-CITY; POLIOVIRUS; CHILDREN; IMMUNITY; CHALLENGE; EMERGENCE;
D O I
10.1126/sciadv.adg6076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Enterovirus D68 (EV-D68) causes severe respiratory illness in children and can result in a debilitating paralytic disease known as acute flaccid myelitis. No treatment or vaccine for EV-D68 infection is available. Here, we dem-onstrate that virus-like particle (VLP) vaccines elicit a protective neutralizing antibody against homologous and heterologous EV-D68 subclades. VLP based on a B1 subclade 2014 outbreak strain elicited comparable B1 EV-D68 neutralizing activity as an inactivated viral particle vaccine in mice. Both immunogens elicited weaker cross -neutralization against heterologous viruses. A B3 VLP vaccine elicited more robust neutralization of B3 subclade viruses with improved cross-neutralization. A balanced CD4+ T helper response was achieved using a carbomer-based adjuvant, Adjuplex. Nonhuman primates immunized with this B3 VLP Adjuplex formulation generated robust neutralizing antibodies against homologous and heterologous subclade viruses. Our results suggest that both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immu-nity against EV-D68.
引用
收藏
页数:14
相关论文
共 62 条
[1]   Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines [J].
Bahar, Mohammad W. ;
Porta, Claudine ;
Fox, Helen ;
Macadam, Andrew J. ;
Fry, Elizabeth E. ;
Stuart, David I. .
NPJ VACCINES, 2021, 6 (01)
[2]  
Benschop KSM, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.45.2100998
[3]  
BROWN F, 1993, DEV BIOL STAND, V81, P103
[4]   Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection [J].
Bungener, Laura ;
Geeraedts, Felix ;
Ter Veer, Wouter ;
Medema, Jeroen ;
Wilschut, Jan ;
Huckriede, Anke .
VACCINE, 2008, 26 (19) :2350-2359
[5]   Acute Flaccid Myelitis Associated With Enterovirus D68: A Review [J].
Christy, Alison ;
Messacar, Kevin .
JOURNAL OF CHILD NEUROLOGY, 2019, 34 (09) :511-516
[6]   Polio eradication at the crossroads [J].
Chumakov, Konstantin ;
Ehrenfeld, Ellie ;
Agol, Vadim, I ;
Wimmer, Eckard .
LANCET GLOBAL HEALTH, 2021, 9 (08) :E1172-E1175
[7]   A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice [J].
Dai, Wenlong ;
Zhang, Chao ;
Zhang, Xueyang ;
Xiong, Pei ;
Liu, Qingwei ;
Gong, Sitang ;
Geng, Lanlan ;
Zhou, Dongming ;
Huang, Zhong .
VACCINE, 2018, 36 (05) :653-659
[8]   Foot-and-mouth disease vaccines [J].
Diaz-San Segundo, Fayna ;
Medina, Gisselle N. ;
Stenfeldt, Carolina ;
Arzt, Jonathan ;
de los Santos, Teresa .
VETERINARY MICROBIOLOGY, 2017, 206 :102-112
[9]   Virus-like particles in picornavirus vaccine development [J].
Dong, Hu ;
Guo, Hui-Chen ;
Sun, Shi-Qi .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2014, 98 (10) :4321-4329
[10]  
Duval M., 2014, VIRUSES